Argenx
ARGX
#408
Rank
A$86.04 B
Marketcap
A$1,382
Share price
-0.63%
Change (1 day)
42.23%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

ESG Reports

Thumbnail Argenx
 ESG Report 2022

ESG Report 2022

Language: English

View ESG Report
Thumbnail Argenx
 ESG Report 2021

ESG Report 2021

Language: English

View ESG Report